Bug in the system: When coronavirus attacked the cyber world

A crisis of global significance

clock • 4 min read

The rapid spread of the coronavirus in Milan forced the Borsa Italiana to cancel our launch event in Italy this week. While disappointing for us, we knew this was for the best.

But as the world has now absorbed, Covid-19 is no ordinary virus. And the Italian situation is certainly no ordinary situation. So much so, in fact, that yesterday Italian officials cut short the Venice Carnival in an effort to control it. According to the World Health Organisation (WHO), the coronavirus now presents "public enemy number one" with infections having exceeded 80,000.  To put that into context, SARS only had 8,098 infections in total.  Coronavirus contagion concerns: Unknown territory But, we have not yet all turned into zombies and China appears to be getting the ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot